1. Home
  2. VXRT vs RFAI Comparison

VXRT vs RFAI Comparison

Compare VXRT & RFAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VXRT
  • RFAI
  • Stock Information
  • Founded
  • VXRT N/A
  • RFAI 2024
  • Country
  • VXRT United States
  • RFAI Singapore
  • Employees
  • VXRT N/A
  • RFAI N/A
  • Industry
  • VXRT Biotechnology: Biological Products (No Diagnostic Substances)
  • RFAI
  • Sector
  • VXRT Health Care
  • RFAI
  • Exchange
  • VXRT Nasdaq
  • RFAI NYSE
  • Market Cap
  • VXRT 170.2M
  • RFAI 154.2M
  • IPO Year
  • VXRT N/A
  • RFAI 2024
  • Fundamental
  • Price
  • VXRT $0.71
  • RFAI $10.31
  • Analyst Decision
  • VXRT Buy
  • RFAI
  • Analyst Count
  • VXRT 1
  • RFAI 0
  • Target Price
  • VXRT $4.00
  • RFAI N/A
  • AVG Volume (30 Days)
  • VXRT 1.2M
  • RFAI 14.5K
  • Earning Date
  • VXRT 03-13-2025
  • RFAI 01-01-0001
  • Dividend Yield
  • VXRT N/A
  • RFAI N/A
  • EPS Growth
  • VXRT N/A
  • RFAI N/A
  • EPS
  • VXRT N/A
  • RFAI N/A
  • Revenue
  • VXRT $16,760,000.00
  • RFAI N/A
  • Revenue This Year
  • VXRT $128.77
  • RFAI N/A
  • Revenue Next Year
  • VXRT N/A
  • RFAI N/A
  • P/E Ratio
  • VXRT N/A
  • RFAI N/A
  • Revenue Growth
  • VXRT 303.27
  • RFAI N/A
  • 52 Week Low
  • VXRT $0.52
  • RFAI $10.00
  • 52 Week High
  • VXRT $1.43
  • RFAI $10.33
  • Technical
  • Relative Strength Index (RSI)
  • VXRT 48.01
  • RFAI N/A
  • Support Level
  • VXRT $0.68
  • RFAI N/A
  • Resistance Level
  • VXRT $0.78
  • RFAI N/A
  • Average True Range (ATR)
  • VXRT 0.05
  • RFAI 0.00
  • MACD
  • VXRT -0.00
  • RFAI 0.00
  • Stochastic Oscillator
  • VXRT 48.85
  • RFAI 0.00

About VXRT Vaxart Inc

Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.

About RFAI RF ACQUISITION CORP II

RF Acquisition Corp II is a blank check company.

Share on Social Networks: